Corporate calendar for Aclaris Therapeutics, Inc. (ACRS): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Aclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inflammatory conditions.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | $-0.02 | |
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 |
Price
| Price | $5.32 |
| Market Cap | $743M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 13 |
| Hold | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 16 |
| Avg rating (1-5) | 0.81 |
Related companies: ALLO · BIOA · CABA · EDIT · MASS · MDXH · NEO
Explore sector: Healthcare · Biotechnology
More sections of ACRS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks